A curated selection of specialized micro-venture capital firms and angel syndicates that actively invest in ultra-early-stage biotechnology companies. These firms are ideal for pre-seed and seed-stage startups with lean teams, offering not just capital but also scientific mentorship, lab access, and regulatory navigation support crucial for deep-tech founders.
Get targeted exposure with custom position pinning and highlighted placement.
While not exclusively biotech, their Life Sciences program specifically supports early-stage bio-founders with technical mentorship and introductions to specialized investors. They provide a structured curriculum and demo day access to a global network of healthcare-focused VCs and pharma partners.
A prominent firm that has made significant strides in deep tech and biotech, often leading early rounds for small, science-driven teams. They offer robust support in talent acquisition and strategy, helping founders navigate the complex path from lab bench to clinical trials.
Focused exclusively on deep tech startups, Redbird Ventures invests in early-stage companies in biotech, life sciences, and industrial tech. They understand the long development cycles and capital intensity of biotech, providing patient capital and strategic guidance tailored to scientific innovation.
One of the most active early-stage angel funds, frequently investing in tiny, high-potential biotech startups. They provide rapid seed funding and access to their extensive network of industry experts, which is invaluable for pre-revenue teams building foundational science.
An early-stage venture studio and fund that takes small equity stakes in companies like 23andMe and Loom. They are particularly adept at supporting small, technical teams in the biotech space, offering hands-on operational support to help founders scale from idea to product.
A specialized early-stage fund focused on deep tech, including biotechnology and healthcare. They target companies with strong scientific foundations but early commercial potential, providing strategic advice on IP strategy, regulatory pathways, and team building for lean startup teams.
Although a large firm, their early-stage biotech investments are notable for supporting small, innovative teams. They have a dedicated healthcare team that identifies promising pre-seed opportunities, offering global reach and connections to corporate partners in the pharmaceutical industry.
Known for their 'First Round Review' content and support for seed-stage companies, First Round actively invests in biotech startups. They provide extensive operational support and a strong network of advisors, helping small teams overcome early-stage hurdles in science and business.
A venture capital firm focused on the convergence of health and technology, investing in early-stage companies. They support small teams developing novel therapeutics or diagnostic tools, offering expertise in healthcare reimbursement, regulatory compliance, and commercial strategy.
A unique investment firm that takes small stakes in many companies, providing flexibility for early-stage biotech founders. They offer a flat fee structure and access to a diverse network, making them an attractive option for startups seeking capital without complex term sheets.
An early-stage firm with a focus on deep tech and social impact, including health equity in biotech. They invest in small teams addressing unmet medical needs, providing strategic support and access to their network of technology and social entrepreneurs.
Known for their disciplined, data-driven approach to seed investing, LowercaseCapital invests in exceptional early-stage teams. They have a history of supporting biotech startups, offering rigorous due diligence and strategic advice to help founders validate their scientific hypotheses.
A Seattle-based early-stage VC that has invested in numerous biotech and life sciences companies. They provide hands-on support in hiring, fundraising, and business development, making them a strong partner for small teams navigating the early stages of commercialization.
A global VC firm with a strong presence in deep tech and biotech, investing in early-stage companies. They offer a global perspective and access to an international network, helping small biotech startups scale their technology and business models across borders.
An early-stage VC firm focused on digital health and biotech, investing in companies transforming healthcare. They provide strategic support in regulatory affairs, clinical trials, and market access, which is critical for small teams building novel therapeutic solutions.
Associated with the Pritzker School of Medicine, this firm invests in early-stage biotech and digital health startups. They leverage academic connections and scientific expertise to support small teams with strong research foundations, offering valuable mentorship and industry access.
A venture capital firm focused on early-stage life sciences and tech companies, investing in small, high-potential startups. They provide strategic guidance on product development, regulatory strategy, and commercialization, helping founders bring innovative therapies to market.
A deep tech investor with multiple funds and programs, including HAX and IndieBio, specifically supporting biotech startups. They offer lab space, mentorship, and capital to early-stage companies, providing a unique ecosystem for scientific innovation and commercialization.
While known for larger rounds, Tiger Global has invested in early-stage biotech companies with strong growth potential. They provide significant capital and strategic resources, helping small teams scale rapidly and navigate the complexities of global markets.
A venture studio and fund focused on early-stage deep tech, including biotech and life sciences. They support small teams with in-house operational capabilities, including hiring, legal, and business development, to accelerate the path from discovery to commercialization.